Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jussuf Kaifi"'
Autor:
Olha Kholod, William Basket, Danlu Liu, Jonathan Mitchem, Jussuf Kaifi, Laura Dooley, Chi-Ren Shyu
Publikováno v:
Cancers; Volume 14; Issue 19; Pages: 4759
(1) Background: Phenotypic and genotypic heterogeneity are characteristic features of cancer patients. To tackle patients’ heterogeneity, immune checkpoint inhibitors (ICIs) represent some the most promising therapeutic approaches. However, approxi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d3db917e2ed445e0dcb206c1ed7c189
Autor:
Xiaogiang Qi, Ming Yang, Lixin Ma, Jonathan Mitchem, Jussuf Kaifi, Shiyou Chen, Aaron Ericsson, Eric Kimchi, Kevin Staveley-O’Carroll, Guangfu Li
Publikováno v:
Cancer Research. 83:4116-4116
Gut microbiota plays a pivotal role in the pathogenesis of hepatocellular cancer (HCC), significantly affecting the HCC treatment. It has been reported that the HCC patients’ response to the immunotherapy of PD-1/PD-L1 blockade was associated with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb2ffa5821f884fadb50f3903a9a1933
https://doi.org/10.1158/1538-7445.am2023-4116
https://doi.org/10.1158/1538-7445.am2023-4116
Autor:
Shu-Kai Chang, Danlu Liu, Jonathan Mitchem, Christos Papageorgiou, Jussuf Kaifi, Chi-Ren Shyu
Publikováno v:
Journal of Biomedical Informatics. 139:104321
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f8587cb25589e9d45614e6b573544b09
https://doi.org/10.1016/j.jbi.2023.104321
https://doi.org/10.1016/j.jbi.2023.104321
Publikováno v:
Cancer Genetics. :29
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4e6d2d4eedfcf79a280f8db26a710172
https://doi.org/10.1016/j.cancergen.2022.10.092
https://doi.org/10.1016/j.cancergen.2022.10.092
Autor:
Jussuf Kaifi, Jonathan Mitchem, Amanda Miller, Yariswamy Manjunath, Mouadh Barbirou, Raju Murugesan, Yuanyuan Shen, Guangfu Li, Diego Avella, Aadel Chaudhuri, Chi-Ren Shyu, Wesley Warren, Peter Tonellato
Publikováno v:
Cancer Genetics. :28
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6774f2be1f6608cc14233c01758973e
https://doi.org/10.1016/j.cancergen.2022.10.090
https://doi.org/10.1016/j.cancergen.2022.10.090
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Xiaoqiang, Qi, Samuel Sk, Lam, Dai, Liu, Dae Young, Kim, Lixin, Ma, Lu, Alleruzzo, Wei, Chen, Tomas, Hode, Carolyn J, Henry, Jussuf, Kaifi, Eric T, Kimchi, Guangfu, Li, Kevin F, Staveley-O'Carroll
Publikováno v:
Journal of clinical & cellular immunology
Manipulation of immune system toward the rejection of established cancers has become the standard of care in some patients. Here we propose the development of an in situ autologous cancer vaccine, inCVAX, for the treatment of hepatocellular cancer (H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::deacad11446e95db4cba0ce3a85c2363
https://pubmed.ncbi.nlm.nih.gov/27656328
https://pubmed.ncbi.nlm.nih.gov/27656328
Autor:
Kevin Staveley-O'Carroll, null Isabelle Deshaies, null Jovenel Cherenfant, Niraj J Gusani, Y Jiang, Harold A. Harvey, Eric T. Kimchi, Jussuf Kaifi, Kevin F Staveley-O'Carroll
Publikováno v:
Therapeutics and Clinical Risk Management
Correspondence: Kevin F StaveleyO’Carroll, MD, PhD Penn State Milton S Hershey Medical Center, Department of Surgery, Mail Code H070, 500 University Drive, P.O. Box 850, Hershey, PA 17033-0850, USA Tel +1 717-531-5965 Fax +1 717-531-3649 email ksoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8b1c22f771059168e4554f1d789f0c0
https://pubmed.ncbi.nlm.nih.gov/20957137
https://pubmed.ncbi.nlm.nih.gov/20957137
Autor:
Kai, Bachmann, Denise, Pawliska, Jussuf, Kaifi, Paulus, Schurr, Jennifer, Zörb, Oliver, Mann, Hans J, Kahl, Jakob R, Izbicki, Tim, Strate
Publikováno v:
Anticancer research. 27(6B)
p53 has been reported to be of prognostic importance in different types of cancer. Immunohistochemical measurement of p53 antigen activity could be a prognostic marker for aggressiveness and survival in thyroid cancer. Different types of antibodies h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::59c9c5d095c9213baea84ef668b184ba
https://pubmed.ncbi.nlm.nih.gov/18225561
https://pubmed.ncbi.nlm.nih.gov/18225561
Autor:
Andreas Marx, Philipp Simon, Ronald Simon, Martina Mirlacher, Jakob Izbicki, Emre Yekebas, Jussuf Kaifi, Luigi Terracciano, Guido Sauter
Publikováno v:
Virchows Archiv: European Journal of Pathology; Sep2008, Vol. 453 Issue 3, p243-248, 6p